OSL (ASX) Ann: Positive Regulatory Updates

Originally posted by milsha77: ↑

Albert- whilst I don't agree with Abdi that this is a scam, it's still one of the funniest things I've read on this forum and it did serve the purpose of nicely chronicling some of the completely over the top (and un-fulfilled) predictions made over time about this stock. There does seem to be a group of cheerleaders here who, despite limited understanding of the data, disease, clinical trials or regulations appear simplistically to view this as some kind of SRX Mk2- and hence we keep reading unscientific and ill-informed claims like the panco trial shows device is " life-saving' (nonsense, NO it's not- any survival advantage is totally unproven at this point) or that it's all BSI's fault because they "set the trial protocol and the dose" (err- NO they don't) . In my view nowhere near enough proper scrutiny has been applied to company performance and the data.

So here's a question: what has the company achieved in the past 5 years? Because anybody looking at this objectively would see that the SP is pretty much at historic lows and lower than the same time 5 years ago, they would also note that there's been no meaningful regulatory success/approval and obviously no commercial revenue in 5 years- and then also study the annual reports and take note of the generous compensation and substantial pay rises awarded to certain company executives. And that person would be entitled to conclude that something doesn't compute.

Bear in mind this technology didn't start with OSL 5 years ago- it's been bumbling along since the mid-2000's originally with psivida. Anywhere else a therapy wouldn't be allowed to get this far because it would be killed off long ago rather than continue to suck in resource for a decade and a half. And all this time, even in something as tough as pancreatic cancer, things evolve and the science moves on. E.G. Check out the MRIdian data recently presented- MRI-guided external stereotactic radiotherapy - CE marked and FDA approved. Delivers a dose to pancreas not that much lower than Oncosil device with survival results it seems at least as good as if not better than OSL- and few side effects. And it seems endorsed by the American Radiation oncology society who've just released guidelines (with thanks to my rad onc mate for alerting me to that). So here's another question: why bother with a device that needs special radiation handling and giving patient GA to pop an endoscope in them and all the extra work for a hospital that that entails if there's something like the MRIdian technology? Because the rate this is going, even if BSI relents and CE mark is eventually given, the device could set some sort of record in the field of medicine as the only therapy that was rendered obsolete on day 1 of marketing!

Expand

Milsha

That’s why the Chinese paid $2 billion for Sirtex? They paid $2 billion for fun? And they just paid a big divvy to their shareholders?

What a load of crap Milsha. Seriously.

Appliances and furnishings impress - will Harvey Norman be next?

Emerald & Azure score Digger & Dealer awards

VTM

Victory Metals dips -8% even as company set to grow heavy REE resource at North Stanmore

MOV

MOVE Logistics picks new interim CEO to take over operations from early September

M2R

EIS co-funded campaign sees Miramar kick off maiden drilling at Bangemall, Gascoyne WA

G88

Golden Mile ditches Marble Bar and Murchison tenements after weak fieldwork results

AWJ

Auric banks $6.3M in August with processing on-target for 300K in 2024

ARD

Argent begins search for VMS mineralisation at Kempfield Cu-Pb-Zn-Au-Ag play in NSW

Bitcoin: Current State of Play & Where to Next | Swyftx

WNX

Wellnex sees first special access scheme prescriptions for new Wellness Life brand

No.	Vol.	Price($)
14	6553895	1.1¢

No.

Vol.

Price($)

6553895

1.1¢

Price($)	Vol.	No.
1.2¢	1917493	5

Price($)

Vol.

No.

1.2¢

1917493

No.	Vol.	Price($)
14	6553895	0.011
15	11480500	0.010
25	14580403	0.009
6	6975000	0.008
14	5470177	0.007

No.

Vol.

Price($)

6553895

0.011

11480500

0.010

14580403

0.009

6975000

0.008

5470177

0.007

Price($)	Vol.	No.
0.012	1917493	5
0.013	11116832	6
0.014	7811217	11
0.015	8500000	3
0.016	3766668	2

Price($)

Vol.

No.

0.012

1917493

0.013

11116832

0.014

7811217

0.015

8500000

0.016

3766668

(20min delay)
Last 1.2¢		Change 0.000(0.00%)		Mkt cap ! $45.40M

Open	High	Low	Value	Volume
1.2¢	1.2¢	1.1¢	$65.61K	5.632M

Ann: Positive Regulatory Updates, page-34

Appliances and furnishings impress - will Harvey Norman be next?

Emerald & Azure score Digger & Dealer awards

Victory Metals dips -8% even as company set to grow heavy REE resource at North Stanmore

MOVE Logistics picks new interim CEO to take over operations from early September

EIS co-funded campaign sees Miramar kick off maiden drilling at Bangemall, Gascoyne WA

Golden Mile ditches Marble Bar and Murchison tenements after weak fieldwork results

Auric banks $6.3M in August with processing on-target for 300K in 2024

Argent begins search for VMS mineralisation at Kempfield Cu-Pb-Zn-Au-Ag play in NSW

Bitcoin: Current State of Play & Where to Next | Swyftx

Wellnex sees first special access scheme prescriptions for new Wellness Life brand

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Positive Regulatory Updates, page-34

Top Stories

Appliances and furnishings impress - will Harvey Norman be next?

Emerald & Azure score Digger & Dealer awards

Victory Metals dips -8% even as company set to grow heavy REE resource at North Stanmore

MOVE Logistics picks new interim CEO to take over operations from early September

EIS co-funded campaign sees Miramar kick off maiden drilling at Bangemall, Gascoyne WA

Golden Mile ditches Marble Bar and Murchison tenements after weak fieldwork results

Auric banks $6.3M in August with processing on-target for 300K in 2024

Argent begins search for VMS mineralisation at Kempfield Cu-Pb-Zn-Au-Ag play in NSW

Bitcoin: Current State of Play & Where to Next | Swyftx

Wellnex sees first special access scheme prescriptions for new Wellness Life brand

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News